🇺🇸 FDA
Patent

US 10633451

Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

granted A61KA61K2039/505A61K39/39558

Quick answer

US patent 10633451 (Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine) held by Ludwig-Maximilians-Universitat Munchen expires Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ludwig-Maximilians-Universitat Munchen
Grant date
Tue Apr 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K39/39558, A61K40/11, A61K40/4204